{"text": "insider brett a pletcher reports selling 1 486 shares of gild for a total cost of 94 152 96"}
{"text": "gild 15s delayed filed sec form 4 insider pletcher brett a disposed 2 593 of common stock at average price 63 59 and acquired 2 927 of common stock at average price 6 49 between 2021 02 15 and 2021 03 11 increased holding by 1 to 29 166 shares"}
{"text": "fwsells gild pletcher brett a evp corp affairs amp gen counsel of gilead sciences inc sold 1 486 shares on 2021 03 11"}
{"text": "as for car t there will be two potential data looks in 2021 phase i in first half and phase ii interim in q 4 this study for hgen with gild may not require a phase iii in addition successful data i combo with yescarta would as translate into nvs amp bmy car t therapies"}
{"text": "gild gilead sciences is a strong cash flow giant stocks investing business"}
{"text": "plz send gild"}
